ERC-2022-POC2
ERC-2022-POC2
Programme: H2020
209 projects · €31,350,000 total EU contribution (project-level) · 146 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€31,350,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (23)
- Spain (20)
- Italy (15)
- Netherlands (15)
- France (14)
- AT (6)
- BE (6)
- PT (6)
- SE (6)
- IL (5)
- CZ (4)
- IE (4)
- NO (4)
- DK (3)
- FI (3)
- PL (3)
- TR (3)
- CH (1)
- CY (1)
- MX (1)
- SI (1)
- UK (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS12 projects · FR
- CSIC8 projects · ES
- TAU8 projects · IL
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY7 projects · IL
- DAY ONE5 projects · IT
- INSERM5 projects · FR
- MPG5 projects · DE
- TECHNICAL UNIVERSITY OF DENMARK DTU4 projects · DK
- KU4 projects · TR
- LMU MUENCHEN4 projects · DE
- LUNDS UNIVERSITET4 projects · SE
- POLIMI4 projects · IT
Projects
Page 18 of 21
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Next Generation Polymyxin Antibiotics: Optimization and Validation NOVA · 101082241 | HORIZON | €150,000 | €0 | Details |
Live biotherapeutics to potentiate cancer immunotherapy LiveBioThx · 101100769 | HORIZON | €150,000 | €0 | Details |
Targeting the Polycomb Machinery in BAP1-related Pathologies T-BAP · 101111993 | HORIZON | €150,000 | €0 | Details |
Novel therapeutic platform for aggressive lymphoma: NanoLymphoma NanoLymphoma · 101112687 | HORIZON | €150,000 | €0 | Details |
Transforming bone cancer therapy with composite biomaterials encapsulating plasma-generated RONS TRANSFORMER · 101082096 | HORIZON | €150,000 | €0 | Details |
Plasma Reactors for Efficient Fertilizer Production Applied in a Real Environment PREPARE · 101081162 | HORIZON | €150,000 | €0 | Details |
Novel T cell therapies against lymphocytic leukaemia CATCH · 101081970 | HORIZON | €150,000 | €0 | Details |
Targeting peripheral nerves: a method for therapeutic modulation of inflammatory disease with non-invasive temporal interference TREATMENT · 101101040 | HORIZON | €150,000 | €0 | Details |
Cherenkov light for total-body Positron Emission Tomography CherPET · 101113474 | HORIZON | €150,000 | €0 | Details |
Metaraminol Demonstration Plant as Commercialisation Blueprint for Sustainable Production of Pharmaceuticals using Enzyme Cascades SusECAS - DemoPlant · 101081888 | HORIZON | €150,000 | €0 | Details |